U.S., Aug. 14 -- ClinicalTrials.gov registry received information related to the study (NCT07119970) titled 'Prognostic Value of NETosis Markers for Thrombosis During Myeloproliferative Neoplasms (AVATARE)' on July 01.
Brief Summary: Myeloproliferative neoplasms are hematologic diseases characterized by an increased proliferation of peripheral blood cells. The main risk of MPN is the occurrence of thrombosis. Thrombosis risk is mainly evaluated using two criteria: age and prior thrombosis. A better prediction of thrombosis risk is needed to improve prevention and treatment of MPN-associated thrombosis. The objective of the study is to evaluate the predictive value of neutrophil extracellular traps markers in thrombosis during MPN.
Study S...